Luiza Barnat, MS, MBA, LMFT, Director | (860) 418-6828 | Luiza.Barnat@ct.gov
Christy Knowles, LCSW, Opioid Projects Lead | (959) 895-0460 | Christy.Knowles@ct.gov
*If you are an organization seeking life-saving naloxone to distribute, please contact Opioid Services Project Lead, Christy Knowles, at Christy.Knowles@ct.gov
What's Trending? - Community Anti-Drug Coalitions of America (CADCA)
2022 Harm Reduction Conference
- Harm Reduction & Health: Addressing Stigma and Human Rights of People Who Use Drugs - Dr. Kimberly Sue
- Bringing People Inside: The Story of the First Legally Sanctioned Injection Site in North America - Liz Evans
- Stigma and Scapegoat: The Opioid in History and Health - Dr. Mishka Terplan
Statewide Opioid Response Webinar Series
- Opioid Services Overview - 10/19/21
- Opioid Services Prevention Initiatives - 11/12/21
- Harm Reduction Strategies - 12/6/21
- Criminal Justice Efforts - 1/7/22
- Women’s Services - 1/20/22
- Recovery Supports - 2/7/22
- Outreach and Engagement - 2/28/22
- Youth, Family and Community Support - 3/11/22
- Women’s Services (CAPTA) - 4/7/22
- Opioid Treatment Initiatives - 4/26/22
Medication Assisted Treatment (MAT) Services & Information:
- CT Behavioral Health Partnership (BHP) Medication Assisted Treatment Locator Map
- Methadone Clinics in CT
- Map of Methadone Clinics in CT
- Information on Medication for Opiate Addiction (Spanish)
- Information on Naltrexone (Spanish)
- Information on Buprenorphine (Spanish)
- The Facts about Buprenorphine
- Medication Assisted Treatment - Information for Family & Friends
- Medication Assisted Treatment Learning Collaborative
- Medication Assisted Treatment for Opioid Use Disorder (Polish)
Recovery Support for Opioid Use Disorder (OUD):
- How Can We Help?
- CT State Opioid Response (SOR) Grant
- Mobile Employment Services
- Prevention and Treatment Resources
Regulations and Guidelines:
- Federal Methadone Exception Requests
- Federal Methadone Regulations
CT BHP - Beacon Health Options Medication Assisted Treatment
The CT BHP is a Partnership that consists of the Departments of Children and Families (DCF), Social Services (DSS), Mental Health and Addiction Services (DMHAS), and Beacon Health Options® designed to create an integrated behavioral health service system for our members.
National Alliance of Advocates for Buprenorphine Treatment
The National Alliance of Advocates for Buprenorphine Treatment is a non-profit organization formed to help people in need of treatment find treatment providers who are willing and able to treat opioid dependency in the privacy of a doctor’s office.
American Association for the Treatment of Opioid Dependence, Inc.
Organization to support the legitimacy of methadone maintenance as a valuable treatment for opioid dependence and to increase the availability of comprehensive treatment services to people in need of care.
American Society of Addiction Medicine
Dedicated to improving access to care, as well as to increase its quality and effectiveness for patients and their families. Working to get addictive medicine and approved medical category
Connecticut Communities for Addiction Recovery (CCAR)
CCAR is an independent, grass-roots level, statewide network made up recovering people, their significant others, families and friends working together towards ensuring that our society will see addiction treatment and recovery as a positive effort in the future.
National Alliance of Methadone Advocates
National Alliance of Methadone Advocates is composed of methadone maintenance patients and supporters of quality treatment. With members and supporters worldwide, as well as state and regional chapters in the U.S.
The 24/7 Access Line, operated by Wheeler and funded by Connecticut’s Department of Mental Health and Addiction Services (DMHAS), facilitates access to Substance Use services for Connecticut residents. Wheeler Staff use a recovery-oriented approach to ask screening questions, and provide callers with education, support, hope and tangible assistance to individuals having difficulty living with substance use issues. Minimally, resource education is provided to each caller on various available treatment options; medications for addiction (e.g., methadone, buprenorphine, naltrexone, naloxone); and various other community programs. The Wheeler staff use the DMHAS CT Addiction website 24/7 to assist callers.
o Same-Day Walk-in Assessment Centers
o DMHAS Funded Substance Use and Mental Health Outpatient Treatment
o Medication for Addiction Treatment (MAT) information
o Withdrawal Management (i.e., detox) programs
o Residential Rehabilitation Facilities dedicated to Substance Use Treatment
Education regarding local and regional harmful illicit substances like Fentanyl
Coordination of DMHAS-funded transportation to and from inpatient/residential programs, if needed as a last resort
Access Line’s role with Withdrawal Management and Residential Rehabilitation Facilities:
Review DMHAS CT Addiction Website, and contact programs as necessary to determine bed availability for those individuals who seek and are already pre-screened for these levels of care;
When a Withdrawal Management Bed or Rehab bed is available, Access Line Staff will conduct a three (3) way conference call with facility to complete the admission Intake;
Answer questions for providers and family members about available levels of care and community resources for individuals and families dealing with substance use and mental health related challenges; and
Provide program names and phone numbers to callers who may be interested in having this information for future reference.
Access Line transportation guidelines:
Access Line provides:
*Transportation from home, hospital, treatment program or other community location to Withdrawal Management (WM) or Substance Use Residential Treatment Programs, provided other possibilities have been explored;
*Transportation from a WM or Substance Use Residential Treatment program to home or other community location, if other transportation options have been explored.
*Transportation from Withdrawal Management (WM) or Residential treatment to home or other location, if the program was not successfully completed or individual leaves against Medical Advice (AMA)
*Transportation to or from MAT or other Outpatient levels of care